More tools:Markets·Screener·Research·Chat

AngioDynamics, Inc. (ANGO) Financial Statements

AngioDynamics, Inc.
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001S5RPY3
XNAS · usd
15.32▲ 0.10 (0.66%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close15.22
Day's Range14.94 – 15.36
52-Week Range9.38 – 16.29
Volume328.8K
Avg Volume397.1K
Share Statistics
Shares Outstanding
Employees675
ExchangeXNAS
Listed2004-05-27
Share count as of July 10, 2026
Loading Income Statement…
Key questions about AngioDynamics, Inc. (ANGO)
What is AngioDynamics, Inc.'s Market Cap?
AngioDynamics, Inc.'s Market Cap is $633.2M, based on as-reported figures from SEC (XBRL) filings.
What is AngioDynamics, Inc.'s Enterprise Value?
AngioDynamics, Inc.'s Enterprise Value is $585.1M, based on as-reported figures from SEC (XBRL) filings.
What is AngioDynamics, Inc.'s Price / Sales?
AngioDynamics, Inc.'s Price / Sales is 2.0×, based on as-reported figures from SEC (XBRL) filings.
What is AngioDynamics, Inc.'s EV / Revenue?
AngioDynamics, Inc.'s EV / Revenue is 1.8×, based on as-reported figures from SEC (XBRL) filings.
What is AngioDynamics, Inc.'s EV / EBITDA?
AngioDynamics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is AngioDynamics, Inc.'s Revenue (TTM)?
AngioDynamics, Inc.'s Revenue (TTM) is $320.2M, based on as-reported figures from SEC (XBRL) filings.
What is AngioDynamics, Inc.'s Net Income (TTM)?
AngioDynamics, Inc.'s Net Income (TTM) is -$36.7M, based on as-reported figures from SEC (XBRL) filings.
What is AngioDynamics, Inc.'s EBITDA?
AngioDynamics, Inc.'s EBITDA is -$17.0M, based on as-reported figures from SEC (XBRL) filings.
What is AngioDynamics, Inc.'s Diluted EPS (TTM)?
AngioDynamics, Inc.'s Diluted EPS (TTM) is -0.89, based on as-reported figures from SEC (XBRL) filings.
What is AngioDynamics, Inc.'s EBITDA Margin?
AngioDynamics, Inc.'s EBITDA Margin is -5.3%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemMay 31, 2026Feb 28, 2026Nov 30, 2025Aug 31, 2025May 31, 2025Feb 28, 2025Nov 30, 2024Aug 31, 2024May 31, 2024Feb 29, 2024Nov 30, 2023Aug 31, 2023May 31, 2023Feb 28, 2023Nov 30, 2022Aug 31, 2022
Net sales
YoY growth+8.0%+8.9%+9.0%+12.2%
Cost of sales (exclusive of intangible amortization)
Gross margin
% of revenue54.0%52.9%56.4%55.3%
Operating expenses
Research and development
Sales and marketing
General and administrative
Amortization of intangibles
Goodwill impairment————
Change in fair value of contingent consideration
Acquisition, restructuring and other items, net
Total operating expenses
% of revenue65.8%69.4%64.1%69.4%
Gain on sale of assets————
Operating loss
% of revenue-11.8%-16.5%-7.7%-14.1%
Other expenses
Interest income (expense), net
Other income (expense), net
Total other income, net——
Loss before income tax expense (benefit)
Income tax expense (benefit)
Net loss
% of revenue-13.2%-10.3%-8.0%-14.4%
Basic (usd per share)
Diluted (usd per share)